HEPSERA

Brand name authorized in: Austria Brazil Canada Cyprus Spain Finland France Hong Kong Ireland Lithuania Netherlands Poland Singapore United Kingdom United States

Active ingredients

The drug HEPSERA contains one active pharmaceutical ingredient (API):

1 Adefovir dipivoxil
UNII U6Q8Z01514 - ADEFOVIR DIPIVOXIL

Adefovir dipivoxil is an oral prodrug of adefovir, an acyclic nucleotide phosphonate analogue of adenosine monophosphate, which is actively transported into mammalian cells where it is converted by host enzymes to adefovir diphosphate. Adefovir diphosphate inhibits viral polymerases by competing for direct binding with the natural substrate (deoxyadenosine triphosphate) and, after incorporation into viral DNA, causes DNA chain termination.

Read about Adefovir dipivoxil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Adefovir dipivoxil
J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF08

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 510610001115217
CA
Health Products and Food Branch
Identifier(s): 02247823
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 03251001
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 014510
FR
Base de données publique des médicaments
Identifier(s): 60954219
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 78426
HK
Department of Health Drug Office
Identifier(s): 65358
IE
Health Products Regulatory Authority
Identifier(s): 88503
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1028725, 1028726, 1075653
NL
Z-Index G-Standaard, PRK
Identifier(s): 70629
PL
Rejestru Produktów Leczniczych
Identifier(s): 100127602
SG
Health Sciences Authority
Identifier(s): 12341P
US
FDA, National Drug Code
Identifier(s): 61958-0501